Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment.

Journal

Journal of hematology & oncology
ISSN: 1756-8722
Titre abrégé: J Hematol Oncol
Pays: England
ID NLM: 101468937

Informations de publication

Date de publication:
24 07 2020
Historique:
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 28 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via the original article.

Identifiants

DOI: 10.1186/s13045-020-00938-7 PMID: 32709244 PMC: PMC7382088
pubmed: 32709244
doi: 10.1186/s13045-020-00938-7
pii: 10.1186/s13045-020-00938-7
pmc: PMC7382088
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

102

Commentaires et corrections

Type : ErratumFor

Références

Med Res Rev. 2020 Mar;40(2):469-494
pubmed: 30004586
J Hematol Oncol. 2020 Mar 30;13(1):26
pubmed: 32228680

Auteurs

Sha-Sha Cheng (SS)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.

Guan-Jun Yang (GJ)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China.

Wanhe Wang (W)

Department of Chemistry, Hong Kong Baptist University, Hong Kong, 999077, China.

Chung-Hang Leung (CH)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China. duncanleung@um.edu.mo.

Dik-Lung Ma (DL)

Department of Chemistry, Hong Kong Baptist University, Hong Kong, 999077, China. edmondma@hkbu.edu.hk.

Classifications MeSH